Biotech Investors & VC Firms in France
115 firms in this list, with a median first check of $635K. 35 of them lead rounds. Generated from verified public data and updated continuously.
Aescap Life Sciences
AmsterdamSeries A–Growth
14 people
Elysia Capital
Turin
7 people
Positron Ventures
AmsterdamPre-Seed–Seed
8 people
Novalis Biotech
GhentPre-Seed–Series A
7 people
another.vc
Mülheim an der RuhrPre-Seed–Seed$108K
3 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Good Startup
BrusselsSeed–Late Stage
5 people
Simsan Ventures
LondonPre-Seed–Series A
6 people
Redstart Labs
IndiaPre-Seed–Series A
2 people
Excellis Holding
TorinoPre-Seed–Seed
2 people
Crista Galli Ventures
LondonPre-Seed–Series A
2 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
dsm-firmenich Venturing
MaastrichtSeed–Growth$108K – $5.4M
9 people
Anais Ventures
LancySeries A–Series C
3 people
Worthwhile Industries Campuses
TorontoLate Stage
Cathay Health
San FranciscoSeed–Late Stage
3 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Next Sequence
2 people
Esperante Ventures
LondonSeed–Series A$540K – $5.4M
1 person
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.




















































